We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Advaxis

News List

Advaxis cuts staff as it seeks partner for troubled cancer vaccine fiercebiotech
June 11, 2018
Just six weeks after taking the helm of biotech Advaxis, CEO Ken Berlin has launched a search for a partner for its stalled lead axalimogene filolisbac (AXAL) and will scale back trials of the immunotherapy in order to bring earlier stage programs forward
New leadership at Advaxis biospectrumasia
April 25, 2018
Kenneth A. Berlin appointed President, CEO and Director; Dr. Andres A. Gutierrez named Chief Medical Officer; Sara Bonstein, CFO, to depart
FDA Halts Advaxis Study Following Patient Death biospace
March 14, 2018
Shares of Advaxis, Inc. announced that the U.S. Food and Drug Administration halted a Phase I/II trial that uses an AstraZeneca Pharmaceuticals LPdrug following the death of a patient.